Congressional Voices — 4 of 5 · Democrat · Massachusetts
Sen. Elizabeth Warren (D-MA)
U.S. Senate · S.3829 Lead Author · S.3822 Co-Author · Singular Legislative Architect of Both Reform Tracks
The Dual-Bill Architecture
Warren is simultaneously pursuing structural separation (S.3822 with Hawley) and executive accountability (S.3829). These are not redundant — they address different failure modes. S.3822 removes the conflict of interest that motivates wrongful denial. S.3829 punishes the executives who executed it. Both are necessary. Neither alone closes the loop.
Tell Them AbilityForge Sent You
This member is on record supporting healthcare accountability reform. Contact them to express your appreciation and urge them to push S.3822 & S.3829 forward. Every constituent call counts — let them know the people they serve are watching.
Sen. Elizabeth Warren is the lead author of S.3829, the Corporate Crimes Against Health Care Act of 2026, introduced February 11, 2026, alongside Senators Markey, Blumenthal, Welch, and Merkley, with House co-lead Rep. Maggie Goodlander (D-NH). She is also co-author of S.3822, the Break Up Big Medicine Act, with Sen. Hawley — making her the singular legislative architect connecting both the structural reform and accountability tracks simultaneously.
S.3829 was introduced in direct response to the bankruptcies of Steward Health Care and Genesis Health — two cases where private equity extraction caused institutional collapse that put patients and communities at catastrophic risk. Warren's framework criminalizes the executive conduct that causes patient harm, empowers state AGs to claw back a decade of compensation, and creates civil penalties of up to five times the clawback amount.
"Private equity companies routinely saddle companies they acquire with massive debt, sell off valuable assets, and extract exorbitant dividends and fees — regardless of how their investments perform. When private equity gets hold of health care systems, it is literally a matter of life and death."
— Sen. Elizabeth Warren (D-MA), S.3829 introduction, February 11, 2026
The Section 7 Distinction
S.3829's Section 7 investigative authority is what separates it from S.3822. Where S.3822 restructures ownership, S.3829 empowers government investigators to subpoena records, audit claim histories, and build the evidentiary record that individual patients could never construct alone. The evidence of wrongful denial lives inside the insurer. Section 7 opens the door.
Rep. Murphy as the Exemplar
Rep. Greg Murphy, MD (R-NC) — a Republican physician-congressman — required eight attempts through CVS/PBM prior authorization to obtain his own medication. He did not use his position to shortcut the process. This is exactly the wrongful denial pattern S.3829's Section 7 investigative authority is designed to audit: documented patient harm caused by insurer conduct that is currently invisible to regulators because the evidence lives inside the company.
See Rep. Murphy's full page →Why S.3829 Gets Less Attention — and Why That Matters
S.3822 has the Warren-Hawley bipartisan signal driving media coverage. S.3829 is a Democratic-only bill targeting private equity, which frames it as partisan even though its accountability mechanisms address harms that cross party lines. Rep. Murphy's eight-attempt prior authorization experience is the argument that S.3829 is not a partisan bill — it is a response to a documented system failure that defeated a Republican physician-congressman doing everything right.
Cross-reference: DocSchmidt
DocSchmidt partnered with Sen. Warren directly to explain S.3822 to a general audience — using the Cardinal Health / GI Alliance merger as the case study.
Read DocSchmidt's coverage →The two-track architecture in full:
S.3822 — Structural
Removes the conflict of interest. Prohibits simultaneous ownership of insurers alongside providers. Mandatory divestiture. Eliminates the architecture that makes wrongful denial profitable.
S.3829 — Accountability
Criminalizes the conduct. Clawback authority over a decade of executive compensation. Section 7 opens the insurer's records to investigators. Names and exposes the executives who made the decisions.
Other Members in This Series